Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients
Conclusions
Celecoxib and diclofenac both provided pain reduction, in addition to improvements in disease activity and functional capacity, in patients with ankylosing spondylitis.
Source: Journal of International Medical Research - Category: Research Authors: Walker, C., Essex, M. N., Li, C., Park, P. W. Tags: Research Reports Source Type: research
More News: Ankylosing Spondylitis | Celebrex | Diarrhoea | Diclofenac | Dyspepsia | Pain | Research | Study | Voltaren